| Literature DB >> 17621369 |
Wei Jiang1, Michael M Lederman, Clifford V Harding, Benigno Rodriguez, Richard J Mohner, Scott F Sieg.
Abstract
Mechanisms that regulate naïve B cell proliferation and function are incompletely defined. In this study, we test the hypothesis that naïve B cell expansion, survival and ability to present antigen to T lymphocytes can be directly modulated by Toll-like receptor (TLR) agonists. In the absence of B cell receptor stimulation, CpG oligonucleotide, a TLR9 agonist, was particularly efficient in inducing naïve B cell proliferation and survival. Although the expanded naïve B cells did not mature into CD27+ or IgG+ memory B cells, these cells did differentiate into IgM-secreting cells with increased surface expression of HLA-DR, CD40 and CD80. This was associated with an increased potential for these B cells to activate allogeneic T cells. We propose that the activation and expansion of naïve B cells induced by TLR9 agonists could enhance the potential of these cells to interact with cognate antigens and facilitate cell-mediated immune responses.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17621369 DOI: 10.1002/eji.200636984
Source DB: PubMed Journal: Eur J Immunol ISSN: 0014-2980 Impact factor: 5.532